Category

News

PamGene shares experience on biomarker development and ICI therapy response prediction at Cancer Bioinformatics Symposium

The 1st Annual Cancer Bioinformatics Symposium at the University of Toledo College of Medicine and Life Sciences will take place February 5th. The full day, online event champions collaboration between...
Read More

Journal for ImmunoTherapy of Cancer publication – Kinase activity profiling as a predictor of response to ICI treatment

Journal for ImmunoTherapy of Cancer published the results of a study focusing on the potential of kinase activity profiling to predict the response of Melanoma and Non Small Cell Lung...
Read More

“Kinases and cell behavior are the basis of my work”

“I’m focused on continuous improvement of therapeutic strategies and to translate these into solutions for patients suffering from lung diseases,” tells Dr. Astrid Weiß, post doc. at the Biomedical Research...
Read More

University Toledo turns supercomputers toward cancer research

“When you combine traditional laboratory techniques with advanced computational biology techniques, you can significantly improve the quality and quantity of your research and produce experimental results that give you much...
Read More

Clinical benefit from immune checkpoint inhibition in advanced melanoma and NSCLC can be predicted by tyrosine kinase activity profiling

Blood-based biomarker test has the potential to decrease the number of both over- and undertreated patients improving overall response rate, reduce unnecessary side effects and help saving costs. PamGene, a...
Read More

PamGene announces presentation of positive interim results for its blood-based biomarker test to predict clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC at the 2020 European Society for Medical Oncology ESMO

PamGene, a biotech and services company focused on the development and commercialization of multiple novel biomarker panels for patient stratification in immuno-oncology, is pleased to announce that new data from...
Read More

Computational Modeling – mini Symposium

The University of Toledo College of Medicine and Life SciencesDepartment of Neurosciences invites you to: A Virtual Mini Symposium: Computation Modeling Signaling Change: Interrogating Protein Kinase signaling with Bioinformatics and Computational...
Read More

The identification of a novel FES substrate

Checking in on Biochemical Kinase behaviour Real-time measurement and understanding of kinase activity serve many purposes. It allows insights in cellular signaling and pathway elucidation but also target interactions. Recently...
Read More

ISO Accreditation for the Diagnostic Assay Services Lab

On February 18, 2019 PamGene has received the Certificate of Approval by Lloyd’s Register for the ISO 13485:2016 for it’s Management System. PamGene has developed a blood-based diagnostic test with...
Read More

At ASCO 2018: Predictive biomarkers for immunotherapy in Melanoma

PamGene is active in the area of diagnostics research and is in the process of developing clinical biomarkers for therapy response. There is an urgent need to properly predict clinical...
Read More
1 2 3